Keywords: high-dose, copaxone, effective, rrms, trial, israeli, drugmaker

High-dose Copaxone effective in RRMS trial

Article | 17 April 2006

Print This

Israeli drugmaker Teva Pharmaceutical says that data from a Phase II trial of its multiple sclerosis drug Copaxone (glatiramer acetate ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in